- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 205/08 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
Patent holdings for IPC class C07D 205/08
Total number of patents in this class: 254
10-year publication summary
|
7
|
21
|
9
|
13
|
11
|
6
|
14
|
8
|
8
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Zhejiang Hisun Pharmaceutical Co., Ltd. | 269 |
10 |
| Bristol-myers Squibb Company | 4883 |
8 |
| Allergan, Inc. | 2445 |
8 |
| eXIthera Pharmaceuticals Inc. | 27 |
7 |
| Merck Sharp & Dohme LLC | 3744 |
7 |
| Microbia, Inc. | 23 |
6 |
| Servier Pharmaceuticals, LLC | 102 |
6 |
| BASF SE | 20387 |
5 |
| AstraZeneca AB | 2961 |
5 |
| Lek Pharmaceuticals d.d. | 211 |
5 |
| Sanofi-Aventis Deutschland GmbH | 2603 |
4 |
| Mayo Foundation for Medical Education and Research | 3102 |
4 |
| Queen's University at Kingston | 534 |
4 |
| Kaneka Corporation | 4493 |
3 |
| Ind-Swift Laboratories Limited | 57 |
3 |
| InterMune, Inc. | 95 |
3 |
| National Institute of Biological Sciences, Beijing | 94 |
3 |
| Orion Corporation | 591 |
3 |
| Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 164 |
3 |
| Teva Pharmaceutical Industries Ltd. | 854 |
3 |
| Other owners | 154 |